Heart Failure

Heart Failure - 2017 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244042

Contents of this Issue

Navigation

Page 50 of 61

51 Table 30. Treating Hypertension to Reduce the Incidence of HF: Recommendation (2017) COR LOE Recommendations I B-R In patients at increased risk, stage A HF, the optimal blood pressure in those with hypertension should be <130/80 mm Hg. Table 31. Recommendation for Hypertension in Stage C HFr EF (2017) COR LOE Recommendations I C-EO Patients with HFrEF and hypertension should be prescribed GDMT titrated to attain systolic blood pressure <130 mm Hg. Table 32. Treating Hypertension in Stage C HFp EF: Recommendation (2017) COR LOE Recommendations I C-LD Patients with HFpEF and persistent hypertension aer management of volume overload should be prescribed GDMT titrated to attain systolic blood pressure <130 mm Hg Table 33. Sleep Disordered Breathing: Recommendations (2017) COR LOE Recommendations IIa C-LD In patients with NYHA class II–IV HF and suspicion of sleep disordered breathing or excessive daytime sleepiness, a formal sleep assessment is reasonable IIb B-R In patients with cardiovascular disease and obstructive sleep apnea, CPAP may be reasonable to improve sleep quality and daytime sleepiness III: Harm B-R In patients with NYHA class II–IV HFrEF and central sleep apnea, adaptive servo-ventilation causes harm

Articles in this issue

view archives of Heart Failure - Heart Failure - 2017 Update